Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Jul;26(1):45–51. doi: 10.1111/j.1365-2125.1988.tb03362.x

Metronidazole excretion in human milk and its effect on the suckling neonate.

C M Passmore 1, J C McElnay 1, E A Rainey 1, P F D'Arcy 1
PMCID: PMC1386498  PMID: 3203060

Abstract

1. Milk and plasma metronidazole and hydroxymetronidazole concentrations were measured in 12 breast-feeding patients following multiple doses of metronidazole (400 mg three times daily). All patients received metronidazole in combination with other broad spectrum antibiotics. 2. Plasma concentrations of both parent drug and metabolite were measured in seven suckling infants. Thirty-five infants were monitored for adverse reactions to maternal metronidazole therapy and two further groups of suckling infants, those whose mothers received either ampicillin alone or no drug therapy, were recruited as controls. 3. The mean milk to plasma ratio (M/P) was 0.9 for metronidazole and 0.76 for hydroxymetronidazole while the mean milk metronidazole concentrations (around Cmax) were 15.5 micrograms ml-1. The mean milk hydroxymetronidazole concentration was 5.7 micrograms ml-1. 4. Infant plasma metronidazole concentrations ranged from 1.27 micrograms ml-1 to 2.41 micrograms ml-1, and the corresponding hydroxymetronidazole concentrations from 1.1 to 2.4 micrograms ml-1. 5. There were no significant increases in adverse effects in infants which could be attributable to maternal metronidazole therapy. 6. Metronidazole was excreted in milk at concentrations which caused no serious reactions in the infants studied. The drug may therefore be administered at doses of 400 mg three times daily to mothers wishing to breast-feed their infants.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amon I., Amon K., Scharp H., Franke G., Nagel F. Disposition kinetics of metronidazole in children. Eur J Clin Pharmacol. 1983;24(1):113–119. doi: 10.1007/BF00613937. [DOI] [PubMed] [Google Scholar]
  2. Beard C. M., Noller K. L., O'Fallon W. M., Kurland L. T., Dockerty M. B. Lack of evidence for cancer due to use of metronidazole. N Engl J Med. 1979 Sep 6;301(10):519–522. doi: 10.1056/NEJM197909063011003. [DOI] [PubMed] [Google Scholar]
  3. Clements C. J. Metronidazole and breast feeding. N Z Med J. 1980 Oct 22;92(670):329–329. [PubMed] [Google Scholar]
  4. Devlin R. G., Duchin K. L., Fleiss P. M. Nadolol in human serum and breast milk. Br J Clin Pharmacol. 1981 Sep;12(3):393–396. doi: 10.1111/j.1365-2125.1981.tb01232.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Erickson S. H., Oppenheim G. L., Smith G. H. Metronidazole in breast milk. Obstet Gynecol. 1981 Jan;57(1):48–50. [PubMed] [Google Scholar]
  6. Evaldson G. R., Lindgren S., Nord C. E., Rane A. T. Tinidazole milk excretion and pharmacokinetics in lactating women. Br J Clin Pharmacol. 1985 Apr;19(4):503–507. doi: 10.1111/j.1365-2125.1985.tb02676.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fleiss P. M., Richwald G. A., Gordon J., Stern M., Frantz M., Devlin R. G. Aztreonam in human serum and breast milk. Br J Clin Pharmacol. 1985 Apr;19(4):509–511. doi: 10.1111/j.1365-2125.1985.tb02677.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRAY M. S., KANE P. O., SQUIRES S. Further observations on metronidazole (Flagyl). Br J Vener Dis. 1961 Dec;37:278–279. doi: 10.1136/sti.37.4.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hackett L. P., Dusci L. J. Determination of metronidazole and tinidazole in human plasma using high-performance liquid chromatography. J Chromatogr. 1979 Jul 13;175(2):347–349. doi: 10.1016/s0021-9673(00)89444-3. [DOI] [PubMed] [Google Scholar]
  10. Heisterberg L., Branebjerg P. E. Blood and milk concentrations of metronidazole in mothers and infants. J Perinat Med. 1983;11(2):114–120. doi: 10.1515/jpme.1983.11.2.114. [DOI] [PubMed] [Google Scholar]
  11. Jager-Roman E., Doyle P. E., Baird-Lambert J., Cvejic M., Buchanan N. Pharmacokinetics and tissue distribution of metronidazole in the new born infant. J Pediatr. 1982 Apr;100(4):651–654. doi: 10.1016/s0022-3476(82)80779-8. [DOI] [PubMed] [Google Scholar]
  12. Meskin M. S., Lien E. J. QSAR analysis of drug excretion into human breast milk. J Clin Hosp Pharm. 1985 Sep;10(3):269–278. doi: 10.1111/j.1365-2710.1985.tb00924.x. [DOI] [PubMed] [Google Scholar]
  13. Moore B., Collier J. Drugs and breast-feeding. Br Med J. 1979 Jul 21;2(6183):211–211. doi: 10.1136/bmj.2.6183.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Okada M., Inoue H., Nakamura Y., Kishimoto M., Suzuki T. Excretion of diltiazem in human milk. N Engl J Med. 1985 Apr 11;312(15):992–993. doi: 10.1056/NEJM198504113121516. [DOI] [PubMed] [Google Scholar]
  15. Orme M. L., Lewis P. J., de Swiet M., Serlin M. J., Sibeon R., Baty J. D., Breckenridge A. M. May mothers given warfarin breast-feed their infants? Br Med J. 1977 Jun 18;1(6076):1564–1565. doi: 10.1136/bmj.1.6076.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Passmore C. M., McElnay J. C., D'Arcy P. F. Drugs taken by mothers in the puerperium: inpatient survey in Northern Ireland. Br Med J (Clin Res Ed) 1984 Dec 8;289(6458):1593–1596. doi: 10.1136/bmj.289.6458.1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Roe F. J. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery. 1983 Jan;93(1 Pt 2):158–164. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES